BTMD SEC Filings: 8-K, 10-Q, S-3 & 424B – biote

Financials

TYPE

HEADLINE

FILED AT

10-Q

NEWForm 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 9, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 7, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 11, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Mar 13, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 7, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 8, 2025

News

TYPE

HEADLINE

FILED AT

8-K

Biote Reports Third Quarter 2026 Financial Results and Maintains Full-Year Outlook

Nov 4, 2026

8-K

Biote Reports Second Quarter 2026 Financial Results and Updates Full-Year Outlook

Aug 5, 2026

8-K/A

Interim CEO Robert Peterson's Employment Agreement Amended, Includes Salary, Incentives, and Stock Options

Jun 17, 2026

8-K

Biote Announces CEO Transition and Reaffirms 2026 Financial Guidance

Jun 2, 2026

8-K

biote Corp. Announces Results of 2026 Annual Meeting of Stockholders

May 18, 2026

8-K

Biote Reports First Quarter 2026 Financial Results

May 6, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B3

UPDATED | SHARE RESALE REGISTRATION | Shares amount: 126,422,286 | Share price: $10.00

Nov 13, 2024

424B3

UPDATED

Nov 13, 2024

424B3

UPDATED | SHARE RESALE REGISTRATION | Shares amount: 126,422,286 | Share price: $0.00 | Warrants amount: 54,352,296

Aug 9, 2024

424B3

UPDATED

Aug 9, 2024

424B3

UPDATED

May 10, 2024

424B3

UPDATED | SHARE RESALE REGISTRATION | Shares amount: 126,422,286 | Share price: $0.00 | Warrants amount: 54,352,296

May 10, 2024

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Apr 14, 2026

POS AM

Form POS AM - Post-Effective amendments for registration statement

Apr 9, 2025

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Apr 9, 2025

S-8

Registration

Apr 4, 2024

POS AM

Up to 5,000,000 Shares of Common Stock EFFECTIVE

Mar 29, 2024

POS AM

Up to 58,565,824 Shares of Class A Common Stock EFFECTIVE

Mar 29, 2024

Proxies

TYPE

HEADLINE

FILED AT

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 2, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 2, 2026

DEFR14A

Form DEFR14A - Revised definitive proxy soliciting materials

May 5, 2025

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 3, 2025

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 3, 2025

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 11, 2024

Ownerships

TYPE

HEADLINE

FILED AT

SCHEDULE 13G/A

AGARWAL AMIT MOHAN (Filed by)

Sep 18, 2026

SCHEDULE 13G/A

AGARWAL AMIT MOHAN (Filed by)

Sep 1, 2026

SCHEDULE 13G

AGARWAL AMIT MOHAN (Filed by)

Aug 28, 2026

Beer Marc D (Reporting)

Aug 12, 2026

SCHEDULE 13G/A

BlackRock, Inc. (Filed by)

Jul 27, 2026

Peterson Robert Charles (Reporting)

Jun 16, 2026

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

Apr 14, 2025

EFFECT

Form EFFECT - Notice of Effectiveness

Apr 3, 2024

EFFECT

Form EFFECT - Notice of Effectiveness

Apr 3, 2024

LETTER

Form UPLOAD - SEC-generated letter

Oct 24, 2023

CORRESP

Form CORRESP - Correspondence

Oct 5, 2023

LETTER

Form UPLOAD - SEC-generated letter

Sep 21, 2023

biote Corp. BTMD · SEC Filings